Sax Wealth Advisors LLC Boosts Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Sax Wealth Advisors LLC grew its position in Mettler-Toledo International Inc. (NYSE:MTD) by 38.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 327 shares of the medical instruments supplier’s stock after purchasing an additional 91 shares during the quarter. Sax Wealth Advisors LLC’s holdings in Mettler-Toledo International were worth $400,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the business. DT Investment Partners LLC grew its stake in shares of Mettler-Toledo International by 13.3% during the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock worth $102,000 after acquiring an additional 8 shares during the last quarter. UMB Bank n.a. increased its stake in shares of Mettler-Toledo International by 8.0% in the third quarter. UMB Bank n.a. now owns 122 shares of the medical instruments supplier’s stock worth $183,000 after acquiring an additional 9 shares during the period. Suncoast Equity Management raised its stake in shares of Mettler-Toledo International by 2.0% during the 3rd quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock valued at $690,000 after buying an additional 9 shares during the last quarter. Bleakley Financial Group LLC raised its position in Mettler-Toledo International by 1.2% during the third quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier’s stock valued at $1,135,000 after acquiring an additional 9 shares in the last quarter. Finally, Huntington National Bank lifted its stake in shares of Mettler-Toledo International by 20.0% in the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after purchasing an additional 9 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Stifel Nicolaus reduced their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Robert W. Baird reduced their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and raised their target price for the company from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Wolfe Research started coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating for the company. Finally, Wells Fargo & Company decreased their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $1,351.25.

Mettler-Toledo International Stock Down 0.1 %

Shares of NYSE:MTD opened at $1,295.77 on Friday. Mettler-Toledo International Inc. has a 52-week low of $1,133.46 and a 52-week high of $1,546.93. The business has a fifty day moving average of $1,241.52 and a two-hundred day moving average of $1,344.05. The stock has a market cap of $27.34 billion, a P/E ratio of 34.94, a PEG ratio of 3.83 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.00 by $0.21. The firm had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. On average, equities analysts anticipate that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Insider Transactions at Mettler-Toledo International

In related news, Director Elisha W. Finney sold 76 shares of the stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. This represents a 24.05 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gerry Keller sold 140 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the sale, the insider now owns 6 shares in the company, valued at $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.